These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 23169720
21. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants. de Krijger RR, Papathomas TG. Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150 [Abstract] [Full Text] [Related]
22. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases. Menon V, Krishnamurthy SV. Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963 [Abstract] [Full Text] [Related]
23. [Current criteria for the diagnosis of adrenocortical carcinoma]. Selivanova LS, Roslyakova AA, Kovalenko YA, Bogolyubova AV, Tertychnyi AS, Beltsevich DG, Abrosimov AY, Melnichenko GA. Arkh Patol; 2019 Jan; 81(3):66-73. PubMed ID: 31317933 [Abstract] [Full Text] [Related]
24. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies. Ribeiro RC, Pinto EM, Zambetti GP. Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338 [Abstract] [Full Text] [Related]
25. The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma. Giordano TJ. Am J Surg Pathol; 2011 Apr; 35(4):471-3. PubMed ID: 21383612 [No Abstract] [Full Text] [Related]
26. Changes in the Evaluation and Management of Adrenocortical Carcinoma. Miller BS. Ann Surg Oncol; 2018 Nov; 25(12):3413-3415. PubMed ID: 30225834 [No Abstract] [Full Text] [Related]
27. Multimodality imaging in a patient with adrenocortical carcinoma leading to peptide receptor radionuclide therapy. Andersen KF, Mellemgaard A, Hendel HW. Clin Nucl Med; 2009 Aug; 34(8):543-8. PubMed ID: 19617743 [No Abstract] [Full Text] [Related]
28. Current and emerging therapies for adrenocortical carcinoma--review. Przytulska J, Rogala N, Bednarek-Tupikowska G. Adv Clin Exp Med; 2015 Aug; 24(2):185-93. PubMed ID: 25931348 [Abstract] [Full Text] [Related]
29. Treatment of adrenocortical carcinoma: contemporary outcomes. Chen DY, Sosa RE, Scherr DS. Curr Urol Rep; 2004 Feb; 5(1):65-72. PubMed ID: 14733841 [Abstract] [Full Text] [Related]
30. Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE). Stigliano A, Chiodini I, Giordano R, Faggiano A, Canu L, Della Casa S, Loli P, Luconi M, Mantero F, Terzolo M. J Endocrinol Invest; 2016 Jan; 39(1):103-21. PubMed ID: 26165270 [No Abstract] [Full Text] [Related]
32. [Adenocarcinoma of the adrenal gland. An accidental finding. Report of a case and review of the literature]. Montilla Y, Rojas CR, Senges E, Bongioanni H, Lindado CE, Diaz R, Sainz O. G E N; 1993 Jun; 47(2):105-10. PubMed ID: 8112534 [Abstract] [Full Text] [Related]
34. [Adrenocortical carcinoma. Current approaches in diagnosis and treatment]. Sapienza P, Tedesco M, Burchi C, Battistini M, Cavallaro A. Ann Ital Chir; 1995 Jun; 66(5):651-63. PubMed ID: 8948804 [Abstract] [Full Text] [Related]
35. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Tömböl Z, Szabó PM, Molnár V, Wiener Z, Tölgyesi G, Horányi J, Riesz P, Reismann P, Patócs A, Likó I, Gaillard RC, Falus A, Rácz K, Igaz P. Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168 [Abstract] [Full Text] [Related]
36. [Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy]. Bertagna X, Groussin L, Libe R, Bertherat J. Bull Acad Natl Med; 2008 Jan; 192(1):87-102; discussion 102-3. PubMed ID: 18663984 [Abstract] [Full Text] [Related]
37. [Malignant tumors of the adrenal: contribution to the repository CCAFU INCa]. Sèbe P, Rigaud J, Avancès C, Brunaud L, Caillard C, Camparo P, Carnaille B, Culine S, Durand X, Mathonnet M, Mirallie E, Soulié M, Oncology Committee of the French Association of Urology (CCAFU). Prog Urol; 2010 Nov; 20 Suppl 4():S310-6. PubMed ID: 21129649 [No Abstract] [Full Text] [Related]
38. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project. Magro G, Esposito G, Cecchetto G, Dall'Igna P, Marcato R, Gambini C, Boldrini R, Collini P, D'Onofrio V, Salfi N, d'Amore E, Ferrari A, Bisogno G, Alaggio R. Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153 [Abstract] [Full Text] [Related]
39. Adrenocortical carcinoma with fat inclusion: case report. Heye S, Woestenborghs H, Van Kerkhove F, Oyen R. Abdom Imaging; 2005 Jan; 30(5):641-3. PubMed ID: 15688105 [Abstract] [Full Text] [Related]